MIT Enterprise Forum
On Septemeber 12, 2017, Pryor Cashman will host the MIT Enterprise Forum. Welcoming remarks will be given by Partner Stephen Goodman, Co-Chair of the firm's Life Sciences Group. Afterwards, Bloomberg Health Reporter, Cynthia Koons, will lead a "fireside chat" with MIT Professor, Sangeeta Bhatvia.
The topic of the lecture will be "How Nano Technology is being used to Diagnose and Treat Disease."
More About the Speakers
Cancer researcher, MIT professor, and biotech entrepreneur Sangeeta Bhatia works to adapt technologies developed in semiconductor manufacturing for medical innovation. Trained as both a physician and engineer, Sangeeta’s laboratory leverages nanotechnology to yield inventions with new applications in tissue regeneration, stem cell differentiation, medical diagnostics, predictive toxicology, and drug delivery.
She and her trainees have launched more than ten biotechnology companies to improve human health. Sangeeta has received many honors including the Lemelson-MIT Prize, and the Heinz Medal for groundbreaking inventions and advocacy for women in STEM fields. She is a Howard Hughes Medical Institute Investigator and an elected member of the National Academy of Engineering and the American Academy of Arts and Science. Her work has been profiled broadly such as in Scientific American, the Boston Globe, Popular Science, Forbes, PBS’s NOVA scienceNOW, The Economist, and MSNBC.
One area that Bhatia has focused on is the early detection and treatment of cancer. She has developed a way to use nanoparticles to seek and find early-stage cancer and detect it with a urinalysis similar to a home pregnancy test. The method could form the basis of an inexpensive point-of-care test that won’t require steady electricity or an on-site physician - ideal for the developing world where cancer is on the rise and resources lag far behind. Finding cancer is only half the battle. Bhatia is also aiming to better treat cancer by developing drug-loaded nanoparticles that seek and destroy cancer cells.
